AbaR4-type resistance island including the blaOXA-23 gene in Acinetobacter nosocomialis isolates

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 8, 2012, Pages 4548-4549

  Kim, Dae Hun ^a   Choi, Ji Young ^a   Jung, Sook In ^b   Thamlikitkul, Visanu ^c   Song, Jae Hoon ^a,d   Ko, Kwan Soo ^a,d  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Chonnam National University Medical School   (South Korea)

^c MAHIDOL UNIVERSITY   (Thailand)

^d Asia Pacific Foundation for Infectious Diseases (APFID)   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAPENEM; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; COLISTIN; COTRIMOXAZOLE; GENTAMICIN; IMIPENEM; MEROPENEM; MESSENGER RNA; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN B;

ACINETOBACTER; ACINETOBACTER NOSOCOMIALIS; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; BLA OXA 23 GENE; GENE EXPRESSION; HOUSEKEEPING GENE; NONHUMAN; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RPOB GENE; SOUTH KOREA; THAILAND;

ACINETOBACTER; ACINETOBACTER INFECTIONS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CARBAPENEMS; CROSS INFECTION; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; REPUBLIC OF KOREA; THAILAND;

EID: 84864390315     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00923-12     Document Type: Article

References (12)

1. Clinical and Laboratory Standards Institute (CLSI). 2011. Performance standards for antimicrobial susceptibility testing, 19th informational supplement, M100-S21. CLSI, Wayne, PA.
2. Ko KS, et al. 2007. High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea. J. Antimicrob. Chemother. 60:1163-1167. (Pubitemid 47617772)
3. Lee K, et al. 2010. Characteristics of clinical isolates of Acinetobacter genomospecies 10 carrying two different metallo-beta-lactamases. Int. J. Antimicrob. Agents 36:259-263.
4. SIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob. Agents Chemother. 49:4485-4491.
5. OXA-23 carbapenemase gene of Acinetobacter baumannii. Emerg. Infect. Dis. 16:35-40.
6. Park YK, et al. 2012. Changes in antimicrobial susceptibility and major clones of Acinetobacter calcoaceticus-baumannii complex isolates from a single hospital in Korea over 7 years. J. Med. Microbiol. 61:71-79.
7. Park YK, Jung SI, Park KH, Kim SH, Ko KS. 2012. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea. Int. J. Antimicrob. Agents 39:81-85.
8. Poirel L, Figueiredo S, Cattoir V, Carattoli A, Nordmann P. 2008. Acinetobacter radioresistens as a silent source of carbapenem resistant for Acinetobacter spp. Antimicrob. Agents Chemother. 52:1252-1256. (Pubitemid 351521984)
9. Post V, White PA, Hall RM. 2010. Evolution of AbaR-type genomic resistance islands in multiply antibiotic-resistant Acinetobacter baumannii. J. Antimicrob. Chemother. 65:1162-1170.
10. Turton JF, Baddal B, Perry C. 2011. Use of accessory genome for characterization and typing of Acinetobacter baumannii. J. Clin. Microbiol. 49:1260-1266.
11. Woodford N, et al. 2006. Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp. Int. J. Antimicrob. Agents 27:351-353.
12. OXA-23 from China. Antimicrob. Agents Chemother. 55:5347-5349.